Skip to content

Diabetes Self-Management & Support LIVE

Diabetes Self-Management & Support LIVE (Learning in Virtual Environments)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02040038
Enrollment
212
Registered
2014-01-20
Start date
2014-07-31
Completion date
2018-03-31
Last updated
2018-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

Diabetes, Virtual Environment, Self-Management

Brief summary

The purpose of this study is to determine whether participation in virtual environment which incorporates real-time diabetes self management and support (DSMT/S) is associated with positive changes in behavior and metabolic outcomes as compared to traditional web-based DSMT/S.

Interventions

BEHAVIORALLIVE

3-D Virtual Environment for DSMT/S

BEHAVIORALWebsite

2-D Website participation for DSMT/S

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Live in close proximity to Duke University Medical Center (DUMC) or NYU Endocrinology Clinic, or Faculty Practice and Bellevue Medical Center to facilitate follow-up research appointments * Diagnosis of Type 2 Diabetes (T2D) * \>= 21 years old * able to read and understand English * access to a computer with broad band internet connection in a private location * reachable by telephone * no pre-existing medical condition(s) or severe diabetes related complications that would interfere with study participation (e.g. * Are able to travel to a clinical lab for blood work

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Change in Dietary Intake18 monthsDietary (fat intake, fruit and vegetable intake) will be assessed at start of the study and at 3, 6, 12 and 18 months
Change in Physical Activity18 monthsChanges in physical activity will be measured using the Fitbit physical activity monitoring at 3, 6, 12, and 18 months.

Secondary

MeasureTime frameDescription
Change in HbA1C level18 monthsMetabolic control (HbA1c) levels will be measured at the start of the study and again at 6, 12, and 18 months
Change in BMI18 monthsBMI will measured at the start of study and at 6, 12, and 18 months.
Change in Lipid Levels18 monthsHigh density lipoprotein (HDL), low density lipoprotein (LDL), total cholesterol (TC) and triglyceride levels will be measured at the start of the study and again at 6, 12 and 18 months.
Change in Blood Pressure18 monthsBlood pressure will be measured at the start of the study and again at 6, 12, and 18 months.
Change in Waist Circumference18 monthsWaist circumference will be measured at start of study and at 6, 12, and 18 months.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026